What Researchers Did
Researchers conducted two independent studies to evaluate hyperbaric oxygen therapy as a supportive treatment for recent acute hearing loss and for acute hearing loss unresponsive to prior treatment.
What They Found
Researchers found that hyperbaric oxygen therapy (HBOT) was superior to standard treatment alone for cochlear perception dysacousis and tinnitus in recent acute hearing loss. However, these benefits were not replicated in cases of acute hearing loss that had previously failed other treatments. The abstract does not provide specific numerical data for these findings.
What This Means for Canadian Patients
Canadian patients experiencing recent acute hearing loss might potentially benefit from hyperbaric oxygen therapy as an adjunctive treatment, under strict medical supervision. However, it appears less effective for hearing loss that has already been treated unsuccessfully.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Germany and published in a German journal.
Study Limitations
A significant limitation is the study's age, published in 1985, which may limit its applicability to current medical practices and understanding.